Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.

AIM To determine whether Helicobacter pylori (H. pylori) infection confers a higher risk of Nonalcoholic fatty liver disease (NAFLD). METHODS Healthy people who underwent health screening were analyzed retrospectively. Inclusion criteria were age ≥ 20 years, history of H. pylori infection, and recorded insulin level. Participants were classified as H. pylori positive or negative according to (13)C urea breath tests. NAFLD was defined using the hepatic steatosis index (HSI) and NAFLD liver fat score (NAFLD-LFS). Those with an HSI > 36 or NAFLD-LFS > -0.640 were considered to have NAFLD. Multivariable logistic regression was performed to identify risk factors for NAFLD. RESULTS Three thousand six hundred and sixty-three people were analyzed and 1636 (44.7%) were H. pylori positive. H. pylori infection was associated with older age, male gender, hypertension, higher body mass index, and a dyslipidemic profile. HSI differed significantly between H. pylori positive and negative subjects (median 33.2, interquartile range (IQR) 30.0-36.2 for H. pylori-positive vs median 32.6, IQR 29.8-36.0 for negative participants, P = 0.005), but NAFLD-LSF did not [median -1.7, IQR -2.4 - -0.7 vs median -1.8, IQR -2.4-(-0.7), respectively, P = 0.122]. The percentage of people with NAFLD did not differ between infected and uninfected groups: HIS, 26.9% vs 27.1%, P = 0.173; NAFLD-LFS, 23.5% vs 23.1%, P = 0.778. H. pylori infection was not a risk factor, but C-reactive protein concentration and smoking were significant risk factors for NAFLD. CONCLUSION H. pylori infection is not a risk factor for NAFLD as indicated by HSI or NAFLD-LFS. Prospective, large-scale studies involving liver biopsies should be considered.

[1]  International Association for the Study of Obesity , 2018, The Grants Register 2019.

[2]  M.,et al.  Changes [I] , 2018, The Complete Poems of William Barnes, Vol. 2: Poems in the Modified Form of the Dorset Dialect.

[3]  Mary E Rinella,et al.  Nonalcoholic fatty liver disease: a systematic review. , 2015, JAMA.

[4]  S. Pettersson,et al.  Helicobacter pylori infection can affect energy modulating hormones and body weight in germ free mice , 2015, Scientific Reports.

[5]  N. Yamamichi,et al.  Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan , 2015, BMC Gastroenterology.

[6]  M. Moriguchi,et al.  Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease , 2015, Journal of Gastroenterology.

[7]  F. Nascimbeni,et al.  Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease , 2014, Alimentary pharmacology & therapeutics.

[8]  Henry Völzke,et al.  Development, External Validation, and Comparative Assessment of a New Diagnostic Score for Hepatic Steatosis , 2014, The American Journal of Gastroenterology.

[9]  J. Kountouras,et al.  Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study. , 2014, Arquivos de gastroenterologia.

[10]  G. Buzás.  Metabolic consequences of Helicobacter pylori infection and eradication. , 2014, World journal of gastroenterology.

[11]  M. Nieuwdorp,et al.  Role of the microbiome in energy regulation and metabolism. , 2014, Gastroenterology.

[12]  Amalia Gastaldelli,et al.  Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance , 2014, PloS one.

[13]  Y. Chawla,et al.  Obesity and NAFLD: the role of bacteria and microbiota. , 2014, Clinics in liver disease.

[14]  Shahab Dowlatshahi,et al.  The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Subjects With Non-Alcoholic Fatty Liver Disease: A Randomized Open-Label Clinical Trial , 2013, Hepatitis monthly.

[15]  Meng Li,et al.  Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. , 2013, World journal of gastroenterology.

[16]  P. Malfertheiner,et al.  Helicobacter pylori infection: selected aspects in clinical management , 2013, Current opinion in gastroenterology.

[17]  F. Mégraud,et al.  Comparative Evaluation of 29 Commercial Helicobacter pylori Serological Kits , 2013, Helicobacter.

[18]  Myung-Gyu Choi,et al.  [A case of celiac disease]. , 2013, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[19]  G. Targher,et al.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis , 2013, Nature Reviews Gastroenterology &Hepatology.

[20]  Lixin Zhu,et al.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.

[21]  D. J. Kim,et al.  Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: A nationwide, multicenter study , 2013, Journal of gastroenterology and hepatology.

[22]  L. Filik,et al.  Association between Helicobacter pylori and liver-to-spleen ratio: a randomized-controlled single-blind study , 2013, European journal of gastroenterology & hepatology.

[23]  J. Kountouras,et al.  Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. , 2013, Metabolism: clinical and experimental.

[24]  S. Rabot,et al.  Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice , 2012, Gut.

[25]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[26]  A. Eshraghian,et al.  Insulin resistance and metabolic syndrome: is Helicobacter pylori criminal? , 2011, Minerva gastroenterologica e dietologica.

[27]  S. Oh.  Obesity and Metabolic Syndrome in Korea , 2011, Diabetes & metabolism journal.

[28]  Identification of Compound Heterozygous Mutation in a Korean Patient with Alpha 1-antitrypsin Deficiency , 2011, The Korean journal of laboratory medicine.

[29]  C. Ki,et al.  Heterogeneous Spectrum of CFTR Gene Mutations in Korean Patients with Cystic Fibrosis , 2011, The Korean journal of laboratory medicine.

[30]  Jannis Kountouras,et al.  The Association Between Helicobacter pylori Infection and Insulin Resistance: A Systematic Review , 2011, Helicobacter.

[31]  Y. Takuma.  [Helicobacter pylori infection and liver diseases]. , 2011, Gan to kagaku ryoho. Cancer & chemotherapy.

[32]  C. Jobin,et al.  High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse , 2010, PloS one.

[33]  H. Kim,et al.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[34]  M. Demir,et al.  Effect of Helicobacter pylori Eradication on Insulin Resistance, Serum Lipids and Low-Grade Inflammation , 2010, Southern medical journal.

[35]  P. Newsome,et al.  Pathogenesis of non-alcoholic fatty liver disease , 2009, QJM : monthly journal of the Association of Physicians.

[36]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[37]  N. Lundbom,et al.  Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.

[38]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[39]  T. van de Wiele,et al.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability , 2009, Gut.

[40]  S. Hashemi,et al.  Helicobacter pylori Infection as a Risk Factor for Insulin Resistance , 2009, Digestive Diseases and Sciences.

[41]  Hajime Sato,et al.  Helicobacter Pylori Infection Is Significantly Associated With Metabolic Syndrome in the Japanese Population , 2008, The American Journal of Gastroenterology.

[42]  Elaine Holmes,et al.  Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes , 2008, Molecular systems biology.

[43]  H. Yoo,et al.  Estimation of Wilson's disease incidence and carrier frequency in the Korean population by screening ATP7B major mutations in newborn filter papers using the SYBR green intercalator method based on the amplification refractory mutation system. , 2008, Genetic testing.

[44]  T. Karakan,et al.  Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases , 2008, European journal of gastroenterology & hepatology.

[45]  E. Kuipers,et al.  Pathogenesis of Helicobacter pylori Infection , 2006, Clinical Microbiology Reviews.

[46]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[47]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[48]  C. Prinz,et al.  Pathogenesis of Helicobacter pylori infection , 2002, Helicobacter.

[49]  C. O'Morain,et al.  Helicobacter pylori Infection , 1994 .

[50]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[51]  Jennifer J. Pointon,et al.  Global prevalence of putative haemochromatosis mutations. , 1997, Journal of medical genetics.

[52]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[53]  A. Larue.  [A case of celiac disease]. , 1952, Laval medical.

[54]  L. Gómezòrozco.  Case of celiac disease , 1951 .